Planned safety analysis of a breast cancer prevention study reveals encouraging news for Exemestane
Sunday, December 14, 2008 - 14:49
in Health & Medicine
An interim analysis of a breast cancer prevention study using exemestane (Aromasin(R)) finds an "acceptable" level of bone loss.